ARTICLE | Clinical News
Neurotech starts glioma Phase I/II
March 30, 2000 8:00 AM UTC
Neurotech (Paris, France) started a French trial of NTC-121, a cell therapy using brain endothelial cells genetically engineered to produce IL-2, for the treatment of high grade glioma. ...